<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01250613</url>
  </required_header>
  <id_info>
    <org_study_id>DMR99-IRB-037</org_study_id>
    <nct_id>NCT01250613</nct_id>
  </id_info>
  <brief_title>Genomic Study of Congenital Malformation</brief_title>
  <official_title>Genomic Study of Congenital Malformation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Academia Sinica, Taiwan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>China Medical University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Genomic aberrations in patients diagnosed as congenital malformation with unknown etiology&#xD;
      will be identified using high-density oligonucleotide array.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Affymetrix GeneChip® Human Mapping SNP 6.0 array, includes more than 900,000 SNP probes&#xD;
      plus more than 900,000 CNV probes in a single chip, can provide high density makers&#xD;
      information for the human genome. The median inter-marker distance is 670 bases and the&#xD;
      average inter-marker distance is 1.67 kb, and the resolution can be as high as 200 kb. The&#xD;
      Affymetrix® Cytogenetics Whole-Genome 2.7M Array gives the greatest power to detect known and&#xD;
      novel chromosome aberrations across the entire genome. In addition, the whole-genome array&#xD;
      includes 400,000 single nucleotide polymorphisms (SNPs) to enable the detection of loss of&#xD;
      heterozygosity (LOH), uniparental disomy (UPD), and regions identical-by-descent.&#xD;
&#xD;
      If we are able to identify the candidate genomic regions that are associated with the&#xD;
      congenital malformation/syndrome, we may have a better chance to understand the pathogenesis&#xD;
      of congenital malformation/syndrome as well as the mechanisms underlying the abnormal&#xD;
      chromosome rare diseases. The results from this study can also facilitate the clinical&#xD;
      diagnosis and provide genetic basis for consultation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2010</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">900</enrollment>
  <condition>Genomic Aberrations in Patients Diagnosed as Congenital Malformation With Unknown Etiology</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Genomic aberrations in patients diagnosed as congenital malformation with unknown etiology&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject is diagnosed as congenital malformation/syndromes.&#xD;
&#xD;
          2. Participants can be any ages, and both males and females are eligible.&#xD;
&#xD;
          3. Subjects agree and are capable of giving informed consent. If participants are under&#xD;
             18 years old or incapable of giving consent, an informed consent must be approved by&#xD;
             their legal guardians.&#xD;
&#xD;
          4. Availability and willingness of the proband and first-degree biological family&#xD;
             (parents, full sibling, or adult-age offspring) who also meets the same congenital&#xD;
             malformation syndrome.&#xD;
&#xD;
          5. Availability and willingness of the proband's biological parents whatever with or&#xD;
             without the same congenital malformation syndrome.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subject or legal guardian is unable to understand or give informed consent.&#xD;
&#xD;
          2. The molecular cause for congenital malformation/syndromes of subjects or their&#xD;
             affected first-degree biological family (parents, full sibling, or adult-age&#xD;
             offspring) can be revealed by karyotype assay or FISH.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>China Medical University Hospital</name>
      <address>
        <city>Taichung</city>
        <zip>406</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fuu-Jen Tsai, PHD</last_name>
      <phone>886-4-22052121</phone>
      <phone_ext>2107</phone_ext>
      <email>d0704@www.cmuh.org.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <study_first_submitted>November 29, 2010</study_first_submitted>
  <study_first_submitted_qc>November 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2010</study_first_posted>
  <last_update_submitted>November 29, 2010</last_update_submitted>
  <last_update_submitted_qc>November 29, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 1, 2010</last_update_posted>
  <responsible_party>
    <name_title>Fuu-Jen Tsai</name_title>
    <organization>China Medical University Hospital</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

